Watch Ticker

Day One Biopharmaceuticals, Inc. Common Stock

Go to Day One Biopharmaceuticals, Inc. Common Stock Website

$5.80

-1.08 (-15.70%)

Live

Previous Close

$5.8

Day Range

$5.635 - $6.1

Previous Day Range

$6.665 - $7.0399

Market Cap

$697.4 million USD

Day Vol.

9.3 million

Previous Day Vol.

4.4 million

Currency

USD

Primary Exchange

Nasdaq

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical devel...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Day One Biopharmaceuticals - Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

Day One Biopharmaceuticals reported Q2 2025 net product revenue of $33.6 million for OJEMDA, a 310% increase from Q2 2024. The company expects full-year 2025 revenue of $140-$150 million and continues advancing its clinical pipeline, including the FIREFLY-2 trial for pediatric low-grade glioma treatment.

Related tickers: DAWN.

Read Full Article

Kuick Research - Global Cancer Antibody Drug Conjugates Market Size Forecast 2030

The global cancer antibody drug conjugates (ADCs) market is expected to surpass $50 billion by 2030, driven by the approval of 16 ADC drugs and over 500 ADCs in clinical trials. The market has experienced substantial growth, reaching over $7 billion in the first half of 2024, with ADCs offering improved efficacy and lower toxicity compared to traditional cancer treatments.

Related tickers: DAWN.

Read Full Article

Trending Tickers

Please sign in to view